Amgen Inc Stock Price To Earnings To Growth
| AMGN34 Stock | BRL 60.11 0.07 0.12% |
Amgen Inc fundamentals help investors to digest information that contributes to Amgen's financial success or failures. It also enables traders to predict the movement of Amgen Stock. The fundamental analysis module provides a way to measure Amgen's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Amgen stock.
Amgen |
Amgen Inc Company Price To Earnings To Growth Analysis
Amgen's PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Current Amgen Price To Earnings To Growth | 1.45 X |
Most of Amgen's fundamental indicators, such as Price To Earnings To Growth, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Amgen Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
| Competition |
Based on the latest financial disclosure, Amgen Inc has a Price To Earnings To Growth of 1.4548 times. This is 104.9% higher than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—General industry. The price to earnings to growth for all Brazil stocks is 70.25% higher than that of the company.
Amgen Price To Earnings To Growth Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Amgen's direct or indirect competition against its Price To Earnings To Growth to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Amgen could also be used in its relative valuation, which is a method of valuing Amgen by comparing valuation metrics of similar companies.Amgen is currently under evaluation in price to earnings to growth category among its peers.
Amgen Fundamentals
| Return On Equity | 1.26 | |||
| Return On Asset | 0.0997 | |||
| Profit Margin | 0.25 % | |||
| Operating Margin | 0.38 % | |||
| Current Valuation | 910.32 B | |||
| Shares Outstanding | 14.95 B | |||
| Price To Earning | 0.83 X | |||
| Price To Book | 39.25 X | |||
| Price To Sales | 29.10 X | |||
| Revenue | 26.32 B | |||
| Gross Profit | 19.92 B | |||
| EBITDA | 12.17 B | |||
| Net Income | 6.55 B | |||
| Cash And Equivalents | 7.18 B | |||
| Cash Per Share | 0.48 X | |||
| Total Debt | 37.35 B | |||
| Current Ratio | 1.53 X | |||
| Book Value Per Share | 0.25 X | |||
| Cash Flow From Operations | 9.72 B | |||
| Earnings Per Share | 2.29 X | |||
| Price To Earnings To Growth | 1.45 X | |||
| Number Of Employees | 25.2 K | |||
| Beta | 0.63 | |||
| Market Capitalization | 685.32 B | |||
| Total Asset | 65.12 B | |||
| Z Score | 10.8 | |||
| Annual Yield | 0.03 % | |||
| Five Year Return | 2.44 % | |||
| Net Asset | 65.12 B | |||
| Last Dividend Paid | 7.76 |
About Amgen Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Amgen Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Amgen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Amgen Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Information and Resources on Investing in Amgen Stock
When determining whether Amgen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Amgen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Amgen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Amgen Inc Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Amgen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.